Applied UV Leverages World Cannabis Day 4:20
April 25 2022 - 8:00AM
Business Wire
Launches New Website and Marketing
Campaign
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announced, that in recognizing the business significance of the
historic 4:20 World Cannabis Day, its wholly owned subsidiary
Sterilumen launched an integrated, multi-touchpoint marketing
campaign targeting the $20B North American Cannabis Market.
The Company has also forged a strategic multi-media-platform
partnership with Cannabis Business Times to educate growers and
operations leaders the criticality of pure, high-quality air in the
grow environment. The campaign includes the redesigned and launch
of the Airoclean420 website, as well as leads-generation ads on
several platforms and advertising across print, e-Newsletter, and
digital video and print platforms. In addition, the Company plans
to exhibit its Airoclean™ 420 by Sterilumen at the Cannabis
Business Times’ Cannabis Conference in Las Vegas August 23-25,
2022. The Cannabis marketing initiative marks the first of many
planned investments into our three acquired Companies (Akida
Holdings, Kes Science and Scientific Air Management) targeting key
verticals of growth that we expect to increase brand recognition,
drive both market share and top line revenue.
John F. Andrews, Applied UV’s Chief Executive Officer commented,
“We are proactively pursuing the high growth cannabis market with
the launch of this multi-faceted marketing program. Healthy air is
an essential element in growing cannabis and can determine whether
the yield produced will be a bumper crop or a total flop. Our
Airoclean™ 420 by Sterilumen, dramatically improves crop yield by
purifying the air in the growing environment by trapping and
destroying all airborne powdery mildew and other fungal diseases.
We believe there is tremendous opportunity for our solutions to
improve the operations of cannabis growers. We are getting this
message out to the industry through the launch of the airoclean420
website and other related marketing initiatives.”
Airoclean™ 420 by Sterilumen launched in 2015 is a pioneering
brand that has been trusted for more than a decade by commercial
and home/hobby growers across North America and, is the most
effective air purification system in destroying powdery mildew and
airborne fungal diseases that ruin cannabis plants and businesses.
The cannabis crop is subject to many viruses that could impede
growth and destroy crops. Powdery mildew is one of the most potent
destroyers of cannabis grows in the world. The pathogen spreads
through the air and gets into the vascular system of the plants. It
remains hidden until two weeks into flowering before it wreaks
havoc on the entire grow. When it is detected, growers must destroy
the crop, remove all their equipment, and conduct an intensive and
costly deep clean. Certain fungicides can combat powdery mildew,
but these are illegal in some states and are of questionable safety
given they are sprayed on something intended for human consumption.
Airoclean™ 420 by Sterilumen eradicates powdery mildew and other
airborne pathogens and not only protects the crops but helps
protect the personnel from airborne pathogens working in the
facilities growing them as well.
For additional information about the Company’s Cannabis
products, please visit https://www.airoclean420.com/.
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven, and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following website:
https://www.applieduvinc.com/;
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
For additional Company Information:
Applied UV Inc. John F. Andrews CEO/Director
john.andrews@applieduvinc.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220425005366/en/
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Sep 2023 to Sep 2024